Search research articles
Contact Us
Filters
Showing results (171-180 of 386) with videos related to
Page
of 39
Sort By:
Journal of Hepatology
|
November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
Jorg Petersen, Vlad Ratziu, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 19, 2023
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study
Anna Feliu-Prius, Ana Barreira-Díaz, Ariadna Rando, et al.
Gastroenterologia Y Hepatologia
|
October 2, 2018
Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)
Jose L Calleja, Juan Macias, Xavier Forns, et al.
Plos One
|
July 1, 2016
Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection
Maria Homs, Francisco Rodriguez-Frias, Josep Gregori, et al.
Plos One
|
July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Transplantation
|
December 2, 2016
Successful Continuation of HCV Treatment After Liver Transplantation
Carlos Fernández Carrillo, Gonzalo Crespo, Juan de la Revilla, et al.
JHEP Reports : Innovation in Hepatology
|
February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
Christiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
BMC Medicine
|
May 4, 2017
Late presentation of chronic viral hepatitis for medical care: a consensus definition
Stefan Mauss, Stanislas Pol, Maria Buti, et al.
Digestive Diseases and Sciences
|
September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B
Naoky C Tsai, Patrick Marcellin, Maria Buti, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study
Pietro Lampertico, Thomas Berg, Maria Buti, et al.
Page
of 39
Search research articles
Search
Showing results (171-180 of 386) with videos related to
Sort By:
Page
of 39
Journal of Hepatology
|
November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
Jorg Petersen, Vlad Ratziu, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 19, 2023
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study
Anna Feliu-Prius, Ana Barreira-Díaz, Ariadna Rando, et al.
Gastroenterologia Y Hepatologia
|
October 2, 2018
Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)
Jose L Calleja, Juan Macias, Xavier Forns, et al.
Plos One
|
July 1, 2016
Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection
Maria Homs, Francisco Rodriguez-Frias, Josep Gregori, et al.
Plos One
|
July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Transplantation
|
December 2, 2016
Successful Continuation of HCV Treatment After Liver Transplantation
Carlos Fernández Carrillo, Gonzalo Crespo, Juan de la Revilla, et al.
JHEP Reports : Innovation in Hepatology
|
February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
Christiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
BMC Medicine
|
May 4, 2017
Late presentation of chronic viral hepatitis for medical care: a consensus definition
Stefan Mauss, Stanislas Pol, Maria Buti, et al.
Digestive Diseases and Sciences
|
September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B
Naoky C Tsai, Patrick Marcellin, Maria Buti, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study
Pietro Lampertico, Thomas Berg, Maria Buti, et al.
Page
of 39